Zeng-jie Yang

NIH Rank #6853
  • R01 Award PI

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11184894Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$1.1M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#6,853
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Zeng-jie Yang as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA290043-02R01
    Thyroid Hormone Inhibits Medulloblastoma Growth by Inducing Tumor Cell Differentiation
    $423.5K
    award amount
  • 5R01CA276273-04R01
    Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment
    $412.5K
    award amount
  • 5R21CA296696-02R21
    Assessment of Efficacy and Toxicity of T3 for Medulloblastoma Treatment
    $264.2K
    award amount

Award organization

Organizations that administered FY2026 awards listing Zeng-jie Yang as a PI.

FY2026 award administered by Fox Chase Cancer Center (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    ScienceDex Coverage Begins
    Earliest loaded PI award records: FY2024
  2. 2025
    $500K Cumulative Linked Award Amount
  3. 2025
    $1M Cumulative Linked Award Amount
  4. 2025
    R01 Award Record
  5. 2026
    $2M Cumulative Linked Award Amount
  6. 2026
    Reached Top 50% by Award-Linked Rank
    Ranked #6853